membro de Inovação em Doenças de Populações Negligenciadas (IDPN) Grupo de Pesquisa MEDICAMENTOS ESSENCIAIS E ASSISTÊNCIA FARMACÊUTICA Grupo de Pesquisa
publicações selecionadas A cross-sectional study of quality of life among Brazilian adults with type 1 diabetes treated with insulin glargine: Findings and implications' for publication in Clinical Diabetes. Initiatives and reforms across Scotland in recent years to improve prescribing; findings and global implications of drug prescriptions Prevalence and factors associated with anxiety among university students of health sciences in Brazil: findings and implications Real-world evaluation of the impact of statin intensity on adherence and persistence to therapy: A Scottish population-based study Key characteristics including sex, sexual orientation and internet use associated with worse mental health among university students in Brazil and implications Impact of Generic Prescribing Across Europe Influence of pharmaceutical services organization on the availability of essential medicines in a public health system A cross-sectional study of the quality of life of patients living with type 1 diabetes treated with insulin glargine and neutral protamine hagedorn insulin and the implications. Access to medicines in the Brazilian Unified Health System?s primary health care: assessment of a public policy Strategies to Improve Antimicrobial Utilization with a Special Focus on Developing Countries The Current Situation Regarding Long-Acting Insulin Analogues Including Biosimilars Among African, Asian, European, and South American Countries; Findings and Implications for the Future Strategies to improve the availability of medicines in primary health care in Brazil: findings and implications Fixed dose drug combinations - are they pharmacoeconomically sound? Findings and implications especially for lower- and middle-income countries Ongoing and planned activities to improve the management of patients with Type 1 diabetes across Africa; implications for the future